Literature DB >> 20064593

The genus Scutellaria an ethnopharmacological and phytochemical review.

Xiaofei Shang1, Xirui He, Xiaoying He, Maoxing Li, Ruxue Zhang, Pengcheng Fan, Quanlong Zhang, Zhengping Jia.   

Abstract

Scutellaria (HUANG QIN) (Lamiaceae), which includes about 350 species commonly known as skullcaps, is widespread in Europe, the United States and East Asia. Some species are taken to clear away the heat-evil and expel superficial evils in traditional Chinese medicine (TCM). The present paper reviews the ethnopharmacology, the biological activities and the correlated chemical compounds of Scutellaria species. More than 295 compounds have been isolated, among them flavonoids and diterpenes. Studies show that Scutellaria and its active principles possess wide pharmacological actions, such as antitumor, anti-angiogenesis, hepatoprotective, antioxidant, anticonvulsant, antibacterial and antiviral activities. Currently, effective monomeric compounds or active parts have been screened for pharmacological activity from Scutellaria in vivo and in vitro. Increasing data supports application and exploitation for new drug development. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064593     DOI: 10.1016/j.jep.2010.01.006

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  65 in total

1.  Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae.

Authors:  Chenrui Li; Li Zhang; Limin Zhou; Siu Kwan Wo; Ge Lin; Zhong Zuo
Journal:  AAPS J       Date:  2011-12-14       Impact factor: 4.009

2.  Acylated neo-clerodane type diterpenoids from the aerial parts of Scutellaria coleifolia Levl. (Lamiaceae).

Authors:  Shin-Ichiro Kurimoto; Jian-Xin Pu; Han-Dong Sun; Hirofumi Shibata; Yoshihisa Takaishi; Yoshiki Kashiwada
Journal:  J Nat Med       Date:  2016-01-29       Impact factor: 2.343

3.  Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.

Authors:  Aurélie de Rus Jacquet; Mitali Arun Tambe; Sin Ying Ma; George P McCabe; Jay Hansford C Vest; Jean-Christophe Rochet
Journal:  J Ethnopharmacol       Date:  2017-01-11       Impact factor: 4.360

Review 4.  Scutellaria baicalensis in stroke management: nature's blessing in traditional Eastern medicine.

Authors:  Bhakta Prasad Gaire; Sang-Kwan Moon; Hocheol Kim
Journal:  Chin J Integr Med       Date:  2014-04-22       Impact factor: 1.978

5.  The downregulation of c-Myc and its target gene hTERT is associated with the antiproliferative effects of baicalin on HL-60 cells.

Authors:  Xia Ren; Zhiyong Zhang; Jing Tian; Hengxiao Wang; Guanhua Song; Qiang Guo; Jing Tian; Yang Han; Qiong Liao; Guoqiang Liu; Huifang Ding; Guosheng Jiang
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

6.  The Influence of Compatibility of Rhubarb and Radix Scutellariae on the Pharmacokinetics of Anthraquinones and Flavonoids in Rat Plasma.

Authors:  Yaqing Zhang; Zunjian Zhang; Rui Song
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-06       Impact factor: 2.441

7.  Metabolomic and Transcriptomic Profiling Uncover the Underlying Mechanism of Color Differentiation in Scutellaria baicalensis Georgi. Flowers.

Authors:  Defu Wang; Jiangran Wang; Yufen Wang; Dongzuo Yao; Yanbing Niu
Journal:  Front Plant Sci       Date:  2022-06-09       Impact factor: 6.627

8.  The complete chloroplast genome of Scutellaria meehanioides (Lamiaceae) from Shaanxi Province, China.

Authors:  Caijuan Zhang; Pengguo Xia; Rui Wu; Dennis Mans
Journal:  Mitochondrial DNA B Resour       Date:  2021-05-19       Impact factor: 0.658

9.  Growth inhibition and apoptosis induction of Scutellaria luteo-coerulea Bornm. & Sint. on leukemia cancer cell lines K562 and HL-60.

Authors:  Mahsa Motaez; Seyed Ahmad Emami; Zahra Tayarani-Najaran
Journal:  Avicenna J Phytomed       Date:  2015 Nov-Dec

Review 10.  The Therapeutic Potential of Wogonin Observed in Preclinical Studies.

Authors:  Javad Sharifi-Rad; Jesús Herrera-Bravo; Luis A Salazar; Shabnum Shaheen; Seyed Abdulmajid Ayatollahi; Farzad Kobarfard; Muhammad Imran; Ali Imran; Luísa Custódio; María Dolores López; Mauricio Schoebitz; Miquel Martorell; Manoj Kumar; Hafiz Ansar Rasul Suleria; William C Cho
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.